Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frailty in Long-Term Prostate Cancer Survivors and Its Association With Quality of Life and Emotional Health.

Journal of the National Comprehensive Cancer Network : JNCCN·2024
Same author

Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i.

Cardiovascular diabetology·2024
Same author

Pancreas Transplantation Outcome Predictions-PTOP: A Risk Prediction Tool for Pancreas and Pancreas-Kidney Transplants Based on a European Cohort.

Transplantation direct·2024
Same author

Predicting clinically significant prostate cancer following suspicious mpMRI: analyses from a high-volume center.

World journal of urology·2024
Same author

Reply by Authors.

The Journal of urology·2023
Same author

Prevalence, lifestyle, and risk factors of erectile dysfunction, premature ejaculation, and low libido in middle-aged men: first results of the Bavarian Men's Health-Study.

Andrology·2023
Same journal

Serious mental illness and cancer: A call to action for equitable care.

CA: a cancer journal for clinicians·2026
Same journal

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

CA: a cancer journal for clinicians·2026
Same journal

Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

CA: a cancer journal for clinicians·2026
Same journal

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

CA: a cancer journal for clinicians·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2026

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Screening for prostate cancer.

Otis W Brawley1, Donna P Ankerst, Ian M Thompson

  • 1American Cancer Society, Atlanta, GA, USA.

CA: a Cancer Journal for Clinicians
|July 1, 2009
PubMed
Summary
This summary is machine-generated.

Prostate cancer screening with PSA tests has uncertain benefits. New risk assessment tools and finasteride may help men manage their prostate cancer risk.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Experiment Videos

Last Updated: Jun 22, 2026

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Area of Science:

  • Urology
  • Oncology
  • Public Health

Background:

  • Prostate cancer affects 1 in 6 US men.
  • Prostate-specific antigen (PSA) screening since the 1980s increased diagnosis rates.
  • The impact of PSA screening on mortality versus improved treatments remains unclear.

Purpose of the Study:

  • To evaluate the effectiveness of prostate cancer screening.
  • To discuss risk assessment methods and potential interventions.

Main Methods:

  • Review of recent large randomized trials on PSA screening.
  • Assessment of risk-stratification tools integrating multiple factors.
  • Consideration of finasteride's role in managing screening-detected prostate cancer.

Main Results:

  • Recent trials suggest any benefit from PSA screening is small.
  • Integrated risk assessment tools are available for personalized evaluation.
  • Finasteride may reduce prostate cancer risk in screened men.

Conclusions:

  • Individualized risk assessment is crucial for prostate cancer screening decisions.
  • The benefits of widespread PSA screening are questionable.
  • Finasteride presents a potential chemopreventive option for certain men.